Four-fold structure of vortex core states in Bi2Sr2CaCu2O8 (Bi2212)

We present a detailed study of vortex core spectroscopy in slightly overdoped Bi2Sr2CaCu2O8 using a low temperature scanning tunneling microscope. Inside the vortex core we observe a four-fold symmetric modulation of the local density of states with an energy-independent period of (4.3\pm 0.3)a0. Furthermore we demonstrate that this square modulation is related to the vortex core states which are located at ~6 meV. Since the core-state energy is proportional to the superconducting gap magnitude, our results strongly suggest the existence of a direct relation between the superconducting state and the local electronic modulations in the vortex core.Comment: 5 pages, 4 figures. Submitted to Physical Review Letter

Incompatibilism and the Fixity of the Past

A style of argument that calls into question our freedom (in the sense that involves freedom to do otherwise) has been around for millennia; it can be traced back to Origen. The argument-form makes use of the crucial idea that the past is over-and-done-with and thus fixed; we cannot now do anything about the distant past (or, for that matter, the recent past)—it is now too late. Peter van Inwagen has presented this argument (what he calls the Consequence Argument) in perhaps its clearest and most forceful way, but debate over the argument has arguably reached a stalemate. Recently, however, Wes Holliday has attempted to break this seeming stalemate by presenting a new argument for the Principle of the Fixity of the Past. Holliday’s argument is subtle and ingenious, and worthy of serious consideration, especially given the promise it holds for genuinely advancing this old debate. In what follows, however, we argue that despite its considerable ingenuity, Holliday’s argument fails to convince, and the stalemate appears to remain

Complete Genome Sequences of Three Clinical Listeria monocytogenes Sequence Type 8 Strains from Recent German Listeriosis Outbreaks

We report here the closed genome sequences of three clinical Listeria monocytogenes strains of multilocus sequence typing (MLST) sequence type 8 (ST8). These strains are representatives of three separate listeriosis outbreak clusters (Alpha1, Pi4, and Sigma1) that affected Germany between 2012 and 2020.Peer Reviewe

Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

The rapid outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China followed by its spread around the world poses a serious global concern for public health. To this date, no specific drugs or vaccines are available to treat SARS-CoV-2 despite its close relation to the SARS-CoV virus that caused a similar epidemic in 2003. Thus, there remains an urgent need for the identification and development of specific antiviral therapeutics against SARS-CoV-2. To conquer viral infections, the inhibition of proteases essential for proteolytic processing of viral polyproteins is a conventional therapeutic strategy. In order to find novel inhibitors, we computationally screened a compound library of over 606 million compounds for binding at the recently solved crystal structure of the main protease (M; pro; ) of SARS-CoV-2. A screening of such a vast chemical space for SARS-CoV-2 M; pro; inhibitors has not been reported before. After shape screening, two docking protocols were applied followed by the determination of molecular descriptors relevant for pharmacokinetics to narrow down the number of initial hits. Next, molecular dynamics simulations were conducted to validate the stability of docked binding modes and comprehensively quantify ligand binding energies. After evaluation of potential off-target binding, we report a list of 12 purchasable compounds, with binding affinity to the target protease that is predicted to be more favorable than that of the cocrystallized peptidomimetic compound. In order to quickly advise ongoing therapeutic intervention for patients, we evaluated approved antiviral drugs and other protease inhibitors to provide a list of nine compounds for drug repurposing. Furthermore, we identified the natural compounds (-)-taxifolin and rhamnetin as potential inhibitors of M; pro; . Rhamnetin is already commercially available in pharmacies